Vitalograph expands Clinical Trial services portfolio with centralized DLCO, decentralized spirometry, and integrated oscillometry solutions.

With more than 60 years’ expertise in respiratory diagnostics, Vitalograph is the only company in the world specialized in delivering clinical trial services exclusively for pulmonary function-focused studies. 

Speaking about the recent additions to their portfolio of services, Richard James, Executive Vice President and Chief Operating Officer of Vitalograph Clinical Trials says:

“We have listened to our Sponsors and developed innovative solutions that help them address real challenges, ones they face every day. Our team has in-depth knowledge of study realities, working closely with Sponsors from study design to data delivery. Our goal is always to pre-empt every challenge that may arise, minimizing potential obstacles while maximizing trial efficacy and data reliability. Our new solutions offer Sponsors greater control and oversight of testing, integrated and secure data solutions, and more clinical endpoint solutions, as well as combined ones.” 

At this year’s European Respiratory Society (ERS) International Congress in Milan, Vitalograph is introducing several new solutions to its clinical trials services portfolio.